Drs Peter Salgo, John L. Fox, Ira M. Klein, Michael Kolodziej, Bryan Loy, Irwin W. Tischler, and Christopher Sweeney discuss the high costs associated with oncology drugs and explain how clinical pathway are being implemented to manage drug utilization and incentivize providers.
Drs Loy and Kolodziej explain when considering and developing a clinical pathway, together providers and payers evaluate the clinical efficacy, tolerability/side effect profile, and cost effectiveness of treatments.
Although most pathways are based on evidence, various factors may still make providers unable to resistant to utilizing a specific from utilizing a specific algorithm when treating patients in their practice, comment Drs Tischler and Klein. Dr Tischler notes that if a provider is against utilizing the suggested pathway, there is little that can change his or her thinking. Dr Klein adds that if the provider chooses not to adhere to the pathway, payers may not reimburse for the treatment. Where there may be a dearth of clinical evidence, Dr Sweeney stresses the utility of consensus guidelines in providing optimal care for each cancer patient.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More